Business · 19/05/2021Updated: 10/17/2026 · 1 min read
FDA to Hold Public Meeting on Financial Efficiency of Human Drug User Fee Programs
Summary
The Food and Drug Administration is requesting public input on the financial transparency and efficiency of user fee programs for prescription drugs, biosimilars, and generic drugs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →